Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker rats

Life Sciences

Volumn 75, Issue 14, 2004, Pages 1735-1746

  Li, Yuhao ^a   Peng, Gang ^a   Li, Qian ^a   Wen, Suping ^b   Hsun Wei Huang, Tom ^a   Roufogalis, Basil D ^a   Yamahara, Johji ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^c Pharmafood Institute   (Japan)

Author keywords

Diabetes; Fibrosis; Heart; Postprandial hyperglycemia; Salacia oblonga

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE; GLUCOSE; MANGIFERIN; MESSENGER RNA; SALACIA OBLONGA EXTRACT; SUCROSE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC MODEL; GLUCOSE BLOOD LEVEL; HEART MUSCLE FIBROSIS; HYPERGLYCEMIA; IN VITRO STUDY; MALE; MEDICINAL PLANT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POSTPRANDIAL STATE; RAT; RAT STRAIN; SALACIA OBLONGA;

ALPHA-GLUCOSIDASES; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; CELASTRACEAE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENDOMYOCARDIAL FIBROSIS; GENE EXPRESSION REGULATION; HEART VENTRICLES; HISTOLOGICAL TECHNIQUES; HYPOGLYCEMIA; MALE; PLANT EXTRACTS; RATS; RATS, ZUCKER; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; XANTHONES;

ANIMALIA;

EID: 3242741012     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.013     Document Type: Article

References (35)

1. Abdelaziz N., Colombo F., Mercier I., Calderone A. Nitric oxide attenuates the expression of transforming growth factor-{beta}3 mRNA in rat cardiac fibroblasts via destabilization. Hypertension. 38(2):2001;261-266
2. Akishita M., Iwai M., Wu L., Zhang L., Ouchi Y., Dzau V.J., Horiuchi M. Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice. Circulation. 102(14):2000;1684-1689
3. Assayag P., Carre F., Chevalier B., Delcayre C., Mansier P., Swynghedauw B. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype, I: fibrosis. Cardiovascular Research. 34(3):1997;439-444
4. Baron A.D. Postprandial hyperglycemia and α-glucosidase inhibitors. Diabetes Research and Clinical Practice. 40:1998;S51-S55
5. Border W.A., Ruoslahti E. Transforming growth factor-β1 in disease: the dark side of tissue repair. Journal of Clinic Investigation. 90(1):1992;1-7
6. Cabrero A., Llaverias G., Roglans N., Alegret M., Sanchez R., Adzet T., Laguna J.C., Vazquez M. Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats. Biochemical and Biophysical Research Communications. 260(2):1999;547-556
7. Ceriello A. The emerging role of post-prandial hyperglycemic spikes in the pathogenesis of diabetic complications. Diabetic Medicine. 15(3):1998;188-193
8. Ceriello A., Bortolotti N., Crescentini A., Motz E., Lizzio S., Russo A., Ezsol Z., Tonutti L., Taboga C. Antioxidant defenses are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. European Journal of Clinical Investigation. 28(4):1998;329-333
9. Ceriello A., Bortolotti N., Motz E., Crescentini A., Lizzio S., Russo A., Tonutti L., Taboga C. Meal-generated oxidative stress in type 2 diabetic patients. Diabetes Care. 21(9):1998;1529-1533
10. Ceriello A. The postprandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes/Metabolism and Research Reviews. 16(2):2000;125-132
11. Ceriello A. The possible role of postprandial hyperglycemia in the pathogenesis of diabetic complications. Diabetologia. 46(Suppl):2003;M9-M16
12. Dekker J.M., Hein R.J. Beyond postprandial hyperglycemia: metabolic factors associated with cardiovascular disease. Diabetologia. 45(4):2002;461-475
13. Eghbali M., Tomek R., Sukhatme V.P., Woods C., Bhambi B. Differential effects of transforming growth factor-β1 and phorbol myristate acetate on cardiac fibroblasts. Circulation Research. 69:1991;483-490
14. Giugliano D., Ceriello A., Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 19(3):1996;257-267
15. Karunanayake E.H., Welihinda J., Sirimanne S.R., Sinnadorai G. Oral hypoglycemic activity of some medicinal plants of Sri Lanka. Journal of Ethnopharmacology. 11(2):1984;223-231
16. Kasiske B.L., O'Donnell M.P., Keane W.F. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension. 19(1 Suppl):1992;I110-I115
17. Konukoglu D., Hatemi H., Ozer E.M., Gonen S., Akcay T. The erythrocyte glutathione levels during oral glucose tolerance test. Journal of Endocrinological Investigation. 20(8):1997;471-475
18. Lebovitz H.E. Alpha-glucosidase inhibitors. Endocrinology and Metabolism Clinics of North America. 26(3):1997;539-551
19. Lebovitz H.E. Postprandial hyperglycemic state: importance and consequences. Diabetes Research and Clinical Practice. 40(Suppl):1998;S27-S28
20. Lebovitz H.E. Effect of the postprandial state on nontraditional risk factors. American Journal of Cardiology. 88(6A):2001;20H-25H
21. Lee J.H., McCarty R. Glycemic control of pain threshold in diabetic and control rats. Physiological Behavior. 47(2):1990;225-230
22. Li Y., Kishimoto I., Saito Y., Harada M., Kuwahara K., Izumi T., Takahashi N., Kawakami R., Tanimoto K., Nakagawa Y., Nakanishi M., Adachi Y., Garbers D.L., Fukamizu A., Nakao K. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protection mechanism in the heart. Circulation. 106(13):2002;1722-1728
23. Li Y., Kishimoto I., Saito Y., Harada M., Kuwahara K., Izumi T., Hamanaka I., Takahashi N., Kawakami R., Tanimoto K., Nakagawa Y., Nakanishi M., Adachi Y., Garbers D.L., Fukamizu A., Nakao K. Androgen Contributes to Gender-Related Cardiac Hypertrophy and Fibrosis in Mice Lacking the Gene Encoding Guanylyl Cyclase-A. Endocrinology. 145(2):2004;951-958
24. Petrov V.V., Fagard R.H., Lijnen P.J. Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblasts to myofibroblasts. Hypertension. 39:2002;258-263
25. Riva E., Andreoni G., Bianchi R., Latini R., Luvara G., Jeremic G., Traquandi C., Tuccinardi L. Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes. Pharmacological Research. 37(3):1998;233-240
26. Serasinghe S., Serasinghe P., Yamazaki H., Nishiguchi K., Hombhanje F., Nakanishi S. Oral Hypoglycemic Effect of Salacia reticulata in the Streptozotocin Induced Diabetic Rat. Phytotherapy Research. 4:1990;205-206
27. Shimizu M., Umeda K., Sugihara H., Yoshio H., Ino R., Takeda Y., Okada Y., Nakanishi I. Collagen remodeling in myocardia of patients with diabetes. Journal of Clinical Pathology. 46(1):1993;32-36
28. Swyngheddauw B. Molecular mechanisms of myocardial remodeling. Physiological Reviews. 79(1):1999;215-262
29. Tessier D., Khalil A., Fulop T. Effects of an oral glucose challenge on free radicals/antioxidants balance in an older population with type II diabetes. Journal of Gerontology. 54(11):1999;M541-M545
30. Thye-Ronn P., Sindrup S.H., Arendt-Nielsen L., Brennum J., Hother-Nielsen O., Beck-Nielsen H. Effect of short term hyperglycemia per se on nociceptive and non-nociceptive thresholds. Pain. 56(1):1994;43-49
31. Weber K.T., Brilla C.G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 83(6):1991;1849-1865
32. Yagi K., Kim S., Wanibuchi H., Yamashita T., Yamamura Y., Iwao H. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension. 29(3):1997;728-735
33. Yoshikawa M., Nishida N., Shimoda H., Takada M., Kawahara Y., Matsuda H. Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activites. Yakugaku Zasshi. 121(5):2001;371-378
34. Young R.J., Macintyre C.A., Martin C.N., Prescott R.J., Ewing D.J., Smith A.F., Viberti G., Clarke B.F. Progression of subclinical neuropathy in young patients with Type I (insulin-dependent) diabetes: associated with glycemic control and microangiopathy (microvascular complications). Diabetologia. 29(3):1986;156-161
35. Zimmet P., Alberti K., Shaw J. Global and societal implications of the diabetes epidemic. Nature. 414(6865):2001;782-787